{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:11:11Z","timestamp":1789161071461,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.jaut.2009.11.008","type":"journal-article","created":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T10:30:41Z","timestamp":1261132241000},"page":"J322-J326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Hepatitis C and interferon induced thyroiditis"],"prefix":"10.1016","volume":"34","author":[{"given":"Yaron","family":"Tomer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/er.2008-0015","article-title":"Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms","volume":"29","author":"Huber","year":"2008","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.jaut.2009.11.008_bib2","first-page":"930","article-title":"Evidence for a major role of heredity in Grave's disease: a population-based study of two Danish twin cohorts","volume":"86","author":"Brix","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2009.11.008_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1568-9972(01)00016-7","article-title":"Iodine: an environmental trigger of thyroiditis","volume":"1","author":"Rose","year":"2002","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.jaut.2009.11.008_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaut.2007.01.001","article-title":"Modifying effects of iodine on the immunogenicity of thyroglobulin peptides","volume":"28","author":"Li","year":"2007","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.jaut.2009.11.008_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.autrev.2004.03.003","article-title":"Interferon induced autoimmune thyroid disease (AITD): a model for human autoimmunity","volume":"3","author":"Oppenheim","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2009.11.008_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0950-351X(95)80819-1","article-title":"Infections and autoimmune endocrine disease","volume":"9","author":"Tomer","year":"1995","journal-title":"Bailli\u00e8re's Clin Endocrinol Metab"},{"issue":"3\u20134","key":"10.1016\/j.jaut.2009.11.008_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaut.2009.02.007","article-title":"The etiology of autoimmune thyroid disease: a story of genes and environment","volume":"32","author":"Tomer","year":"2009","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.jaut.2009.11.008_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.amjmed.2004.04.004","article-title":"Hepatitis C and thyroid autoimmunity: is there a link?","volume":"117","author":"Tomer","year":"2004","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.jaut.2009.11.008_bib9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ecl.2007.07.001","article-title":"Interferon alpha treatment and thyroid dysfunction","volume":"36","author":"Tomer","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jaut.2009.11.008_bib10","first-page":"107","article-title":"Infection, thyroid disease and autoimmunity","volume":"14","author":"Tomer","year":"1993","journal-title":"Endocr Rev"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2009.11.008_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/08916938909034358","article-title":"Does infection initiate Grave's disease? A\u00a0population based 10 year study","volume":"4","author":"Cox","year":"1989","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2009.11.008_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2265.1985.tb00225.x","article-title":"The geographical distribution of thyrotoxicosis in England according to the presence or absence of TSH-receptor antibodies","volume":"23","author":"Phillips","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaut.2009.11.008_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.0954-6820.1986.tb03283.x","article-title":"Serological evidence for the role of bacterial infections in the pathogenesis of thyroid diseases","volume":"219","author":"Valtonen","year":"1986","journal-title":"Acta Med Scand"},{"issue":"8575\u20138576","key":"10.1016\/j.jaut.2009.11.008_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(88)91034-3","article-title":"Antibodies to plasmid-encoded proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease [letter]","volume":"1","author":"Wenzel","year":"1988","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jaut.2009.11.008_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/105072502320288483","article-title":"Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies","volume":"12","author":"Corapcioglu","year":"2002","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.jaut.2009.11.008_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2265.2008.03227.x","article-title":"Too early to dismiss Yersinia enterocolitica infection in the aetiology of Grave's disease: evidence from a twin case-control study","volume":"69","author":"Brix","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.jaut.2009.11.008_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1469-0691.2001.00221.x","article-title":"Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis","volume":"7","author":"Chatzipanagiotou","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2009.11.008_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/08820139809070887","article-title":"Relationship between HLA antigens and infectious agents in contributing towards the development of Grave's disease","volume":"27","author":"Kraemer","year":"1998","journal-title":"Immunol Invest"},{"issue":"2","key":"10.1016\/j.jaut.2009.11.008_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2265.2000.01051.x","article-title":"Reverse transcriptase is elevated in the thyroid tissue from Grave's disease patients","volume":"53","author":"Nagasaka","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.jaut.2009.11.008_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/08916939509001938","article-title":"Evidence for a retroviral trigger in Grave's disease","volume":"20","author":"Jaspan","year":"1995","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib21","first-page":"2271","article-title":"The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Grave's disease","volume":"81","author":"Jaspan","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jaut.2009.11.008_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jmv.1890450407","article-title":"Presence of human T-lymphotropic virus type II-related genes in DNA of peripheral leukocytes from patients with autoimmune thyroid diseases","volume":"45","author":"Yokoi","year":"1995","journal-title":"J Med Virol"},{"issue":"8","key":"10.1016\/j.jaut.2009.11.008_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/105072502760258640","article-title":"Cytotoxic T-lymphocyte antigen-4 gene polymorphisms and human T-cell lymphotrophic virus-1 infection: their associations with Hashimoto's thyroiditis in Japanese patients","volume":"12","author":"Tomoyose","year":"2002","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.jaut.2009.11.008_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00004836-199806000-00008","article-title":"Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis","volume":"26","author":"de Luis","year":"1998","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.jaut.2009.11.008_bib25","first-page":"817","article-title":"The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders","volume":"50","author":"Figura","year":"1999","journal-title":"J Physiol Pharmacol"},{"issue":"11","key":"10.1016\/j.jaut.2009.11.008_bib26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1089\/thy.2004.14.964","article-title":"Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens","volume":"14","author":"Benvenga","year":"2004","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.jaut.2009.11.008_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/hep.1840180205","article-title":"High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy","volume":"18","author":"Tran","year":"1993","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2009.11.008_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/jaut.1999.0360","article-title":"Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study","volume":"14","author":"Ganne-Carrie","year":"2000","journal-title":"J Autoimmun"},{"issue":"13","key":"10.1016\/j.jaut.2009.11.008_bib29","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archinte.158.13.1445","article-title":"Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy","volume":"158","author":"Fernandez-Soto","year":"1998","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.jaut.2009.11.008_bib30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/eje.0.1320587","article-title":"Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a","volume":"132","author":"Preziati","year":"1995","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.jaut.2009.11.008_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjmed.2004.01.023","article-title":"Thyroid disorders in chronic hepatitis C","volume":"117","author":"Antonelli","year":"2004","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.jaut.2009.11.008_bib32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/BF03343626","article-title":"Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western Sardinia","volume":"22","author":"Loviselli","year":"1999","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.jaut.2009.11.008_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/thy.1997.7.421","article-title":"Failure to find an association between hepatitis C virus and thyroid autoimmunity","volume":"7","author":"Metcalfe","year":"1997","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0168-8278(95)80216-9","article-title":"Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection","volume":"22","author":"Boadas","year":"1995","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jaut.2009.11.008_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2265.2007.03009.x","article-title":"Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection","volume":"68","author":"Indolfi","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.jaut.2009.11.008_bib36","first-page":"399","article-title":"The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C","volume":"89","author":"Watanabe","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jaut.2009.11.008_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000184606","article-title":"Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis","volume":"44","author":"Carella","year":"1995","journal-title":"Horm Res"},{"issue":"5","key":"10.1016\/j.jaut.2009.11.008_bib38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0002-9343(96)00259-8","article-title":"Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha","volume":"101","author":"Roti","year":"1996","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2265.1996.751768.x","article-title":"Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy","volume":"44","author":"Marazuela","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1530\/eje.0.1460743","article-title":"The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism","volume":"146","author":"Carella","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/thy.2006.16.563","article-title":"Thyroid disorders in chronic hepatitis C virus infection","volume":"16","author":"Antonelli","year":"2006","journal-title":"Thyroid"},{"issue":"6690","key":"10.1016\/j.jaut.2009.11.008_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/28282","article-title":"Autoimmunity. The pathogen connection","volume":"394","author":"Benoist","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2009.11.008_bib43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0092-8674(87)90507-1","article-title":"Molecular mimicry and autoimmune diseases","volume":"50","author":"Oldstone","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2009.11.008_bib44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-85-6-735","article-title":"Antibodies to Yersinia enterocolitica in thyroid disease","volume":"85","author":"Shenkman","year":"1976","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jaut.2009.11.008_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/jaut.2000.0482","article-title":"Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals","volume":"16","author":"Fournie","year":"2001","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.jaut.2009.11.008_bib46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2006.03.011","article-title":"By-stander activation in autoimmune thyroiditis: studies on experimental autoimmune thyroiditis in the GFP+ fluorescent mouse","volume":"121","author":"Arata","year":"2006","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.jaut.2009.11.008_bib47","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/jmv.21269","article-title":"Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection","volume":"80","author":"Bartolome","year":"2008","journal-title":"J Med Virol"},{"issue":"8","key":"10.1016\/j.jaut.2009.11.008_bib48","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/378643","article-title":"Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism","volume":"188","author":"Munshi","year":"2003","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.jaut.2009.11.008_bib49","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/505708","article-title":"Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes","volume":"194","author":"Balasubramanian","year":"2006","journal-title":"J Infect Dis"},{"issue":"37","key":"10.1016\/j.jaut.2009.11.008_bib50","doi-asserted-by":"crossref","first-page":"35755","DOI":"10.1074\/jbc.M302889200","article-title":"Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes","volume":"278","author":"Balasubramanian","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jaut.2009.11.008_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaut.2008.08.001","article-title":"HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity","volume":"31","author":"Akeno","year":"2008","journal-title":"J Autoimmun"},{"issue":"12","key":"10.1016\/j.jaut.2009.11.008_bib52","first-page":"2489","article-title":"Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons","volume":"58","author":"Pfeffer","year":"1998","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib53","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00001622-200311000-00005","article-title":"Interferons: mechanisms of action and clinical applications","volume":"15","author":"Parmar","year":"2003","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"10.1016\/j.jaut.2009.11.008_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.6-1-34","article-title":"Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities","volume":"6","author":"Jonasch","year":"2001","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.jaut.2009.11.008_bib55","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.1991.03470100067035","article-title":"The interferons. Mechanisms of action and clinical applications","volume":"266","author":"Baron","year":"1991","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.jaut.2009.11.008_bib56","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib57","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0016-5085(03)00394-9","article-title":"Side effects of therapy for chronic hepatitis C","volume":"124","author":"Russo","year":"2003","journal-title":"Gastroenterology"},{"issue":"8438","key":"10.1016\/j.jaut.2009.11.008_bib58","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(85)92475-4","article-title":"Primary hypothyroidism associated with interferon therapy of breast cancer","volume":"1","author":"Fentiman","year":"1985","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jaut.2009.11.008_bib59","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","article-title":"The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification","volume":"43","author":"Mandac","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2009.11.008_bib60","first-page":"49","article-title":"Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease","volume":"22","author":"Martocchia","year":"2001","journal-title":"Neuro Endocrinol Lett"},{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib61","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2265.1993.tb02423.x","article-title":"Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C","volume":"39","author":"Baudin","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.jaut.2009.11.008_bib62","first-page":"1925","article-title":"Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment","volume":"86","author":"Carella","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib63","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2265.2002.01553.x","article-title":"Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis","volume":"56","author":"Wong","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib64","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/0016-5085(92)90348-3","article-title":"Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa","volume":"102","author":"Lisker-Melman","year":"1992","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jaut.2009.11.008_bib65","first-page":"922","article-title":"Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis","volume":"80","author":"Imagawa","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaut.2009.11.008_bib66","first-page":"1","article-title":"Persistent thyroid autoimmunity after subacute thyroiditis","volume":"23","author":"Weetman","year":"1987","journal-title":"J Clin Lab Immunol"},{"issue":"5","key":"10.1016\/j.jaut.2009.11.008_bib67","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2893.2000.00247.x","article-title":"Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus","volume":"7","author":"Parana","year":"2000","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.jaut.2009.11.008_bib68","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1210\/jc.2004-1173","article-title":"Type I interferons modulate the expression of thyroid peroxidase, sodium\/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures","volume":"90","author":"Caraccio","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5589","key":"10.1016\/j.jaut.2009.11.008_bib69","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1126\/science.1074900","article-title":"Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection","volume":"297","author":"Nguyen","year":"2002","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jaut.2009.11.008_bib70","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/107999000750053690","article-title":"Biologic responses to IFN-alpha administration in humans","volume":"20","author":"Corssmit","year":"2000","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"10.1016\/j.jaut.2009.11.008_bib71","first-page":"61","article-title":"Expression of ICAM-1, B7.1 and TPO on human thyrocytes induced by IFN-alpha","volume":"112","author":"You","year":"1999","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"10.1016\/j.jaut.2009.11.008_bib72","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0167-5699(00)01710-2","article-title":"Type I interferons and T helper development","volume":"21","author":"Farrar","year":"2000","journal-title":"Immunol Today"},{"issue":"3","key":"10.1016\/j.jaut.2009.11.008_bib73","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/gast.1997.v112.pm9041265","article-title":"New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine","volume":"112","author":"Tilg","year":"1997","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jaut.2009.11.008_bib74","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2249.1997.269-ce1161.x","article-title":"Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans","volume":"107","author":"Corssmit","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.jaut.2009.11.008_bib75","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9343(03)00390-5","article-title":"Autoimmune aspects of cytokine and anticytokine therapies","volume":"115","author":"Krause","year":"2003","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.jaut.2009.11.008_bib76","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1073\/pnas.70.10.2785","article-title":"Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells","volume":"70","author":"Lindahl","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaut.2009.11.008_bib77","unstructured":"Akeno N, Tomer Y. Dissecting the mechanisms of interferon induced thyroiditis (IIT): direct effects of interferon alpha on thyroid epithelial cells. In: The 89th meeting of the endocrine society, Toronto, Canada; June 2007."},{"issue":"2","key":"10.1016\/j.jaut.2009.11.008_bib78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/thy.2008.0290","article-title":"Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures","volume":"19","author":"Caraccio","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.jaut.2009.11.008_bib79","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1210\/er.2002-0030","article-title":"Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function","volume":"24","author":"Tomer","year":"2003","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.jaut.2009.11.008_bib80","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2796.2002.00974.x","article-title":"Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy","volume":"251","author":"Dalgard","year":"2002","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.jaut.2009.11.008_bib81","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/105072503322238809","article-title":"Interferon-alpha and autoimmune thyroid disease","volume":"13","author":"Prummel","year":"2003","journal-title":"Thyroid"},{"issue":"4\u20136","key":"10.1016\/j.jaut.2009.11.008_bib82","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0960-0760(91)90287-F","article-title":"Sex steroid regulation of autoimmunity","volume":"40","author":"Grossman","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"10.1016\/j.jaut.2009.11.008_bib83","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1210\/jc.2008-0364","article-title":"Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease","volume":"93","author":"Ban","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2\u20134","key":"10.1016\/j.jaut.2009.11.008_bib84","first-page":"161","article-title":"The effects of alpha interferon on the development of autoimmune thyroiditis in the NOD H2h4 mouse","volume":"10","author":"Oppenheim","year":"2003","journal-title":"Clin Dev Immunol"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2009.11.008_bib85","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2007.11.010","article-title":"The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology","volume":"30","author":"Jacobson","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.11.008_bib86","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2007.02.006","article-title":"The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future","volume":"28","author":"Jacobson","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.11.008_bib87","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaut.2007.02.016","article-title":"The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts","volume":"28","author":"Ban","year":"2007","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.jaut.2009.11.008_bib88","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0168-8278(99)80131-7","article-title":"HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C","volume":"30","author":"Kakizaki","year":"1999","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2009.11.008_bib89","first-page":"221","article-title":"Thyroid gland dysfunctions during antiviral therapy of chronic hepatitis C","volume":"7","author":"Kryczka","year":"2001","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jaut.2009.11.008_bib90","first-page":"926","article-title":"Immune-regulatory gene involvement in the etiology of interferon induced thyroiditis (IIT)","volume":"16","author":"Jacobson","year":"2006","journal-title":"Thyroid"},{"issue":"2\u20133","key":"10.1016\/j.jaut.2009.11.008_bib91","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2007.02.008","article-title":"Pharmacogenomics and its implications for autoimmune disease","volume":"28","author":"Ross","year":"2007","journal-title":"J Autoimmun"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841109001486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841109001486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:06:15Z","timestamp":1760256375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841109001486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0896841109001486"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2009.11.008","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C and interferon induced thyroiditis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2009.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}